CVS Health Corp issued an optimistic guidance for 2025 stemming from the expected recovery in its insurance business — ...

CVS Health Corporation reported financial results for the fourth quarter and full year of 2024, highlighting challenges ...

CVS Health is seeing signs of stabilization in key business areas, prompting Leerink Partners to upgrade the stock from Market Perform to Outperform and raise its price target to $75 per share in a ...

Larry McGrath; Executive Vice President, Chief Strategy Officer and Chief Strategic Advisor to the CEO of CVS Health; CVS Health Corp David Joyner; President and Chief Executive Officer; CVS Health ...

CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings surpassing analysts’ ...

BofA raised the firm’s price target on CVS Health (CVS) to $75 from $63 and keeps a Buy rating on the shares. Aetna can add $3-$4 per share of ...

A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits ...

Shares of CVS Health Corp. continued climbing premarket Thursday after a blockbuster session driven by stronger-than-expected quarterly earnings. The stock surged nearly 15% on Wednesday, marking its ...

CVS Health’s adjusted fourth-quarter profit handily beat Wall Street’s estimates, even as the drugstore chain and pharmacy ...

CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a ...

CVS Health Corporation (NYSE:CVS) is a retailer that operates in four segments: health care benefits, health services, ...

CVS Health exceeded Q4 sales estimates with $97.71B revenue. The company projects 2025 revenue above $134B and expects ...